These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 20357686

  • 1. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I, Lukac J, Marić-Brozić J, Buljan M, Alajbeg I, Kovacević D, Situm M, Kusić Z.
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [Abstract] [Full Text] [Related]

  • 2. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
    Samija I, Lukac J, Marić-Brozić J, Kusić Z.
    Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
    [Abstract] [Full Text] [Related]

  • 3. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C, Andres R, Mayordomo JI, Martinez-Lorenzo MJ, Murillo L, Sáez-Gutiérrez B, Diestre C, Marcos I, Astier P, Godino J, Carapeto-Marquez de Prado FJ, Larrad L, Tres A.
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [Abstract] [Full Text] [Related]

  • 4. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P, Osella-Abate S, Cappello N, Ortoncelli M, Nardò T, Fierro MT, Cavallo F, Savoia P, Bernengo MG.
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [Abstract] [Full Text] [Related]

  • 5. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, Thiel E, Foerster MH, Keilholz U.
    Clin Cancer Res; 2007 Feb 15; 13(4):1171-8. PubMed ID: 17317826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F, Chtourou M, Teyssier JR, Laubriet A, Mougin CH, Blanc D, Humbert P.
    Melanoma Res; 2000 Apr 15; 10(2):113-8. PubMed ID: 10803711
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
    Mellado B, Gutierrez L, Castel T, Colomer D, Fontanillas M, Castro J, Estapé J.
    Clin Cancer Res; 1999 Jul 15; 5(7):1843-8. PubMed ID: 10430090
    [Abstract] [Full Text] [Related]

  • 9. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P, Mazzini C, Salvianti F, Massi D, Grifoni R, Paoletti C, Ucci F, Molinara E, Orlando C, Pazzagli M, Neri B.
    Melanoma Res; 2010 Aug 15; 20(4):303-10. PubMed ID: 20442676
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
    Glumac N, Snoj M, Hocevar M, Novakovic S.
    Neoplasma; 2006 Aug 15; 53(1):9-14. PubMed ID: 16416006
    [Abstract] [Full Text] [Related]

  • 11. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ, Fourkour A, Punt CJ, van de Locht LT, Wobbes T, van den Bosch S, de Rooij MJ, Mensink EJ, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 May 15; 80(5-6):883-91. PubMed ID: 10360670
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R, Mayordomo JI, Visus C, Isla D, Godino J, Escudero P, Saenz A, Ortega E, Lastra R, Lambea J, Aguirre E, Elosegui L, Marcos I, Ruiz-Echarri M, Millastre E, Sáez-Gutierrez B, Asin L, Vidal MJ, Ferrer A, Giner A, Larrad L, Carapeto FJ, Tres A.
    Am J Clin Oncol; 2008 Aug 15; 31(4):335-9. PubMed ID: 18845991
    [Abstract] [Full Text] [Related]

  • 13. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL, Scheer WD, Levine EA.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 15; 5(4):293-6. PubMed ID: 8722221
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
    Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A, Rosai J.
    Clin Cancer Res; 1998 Feb 15; 4(2):419-28. PubMed ID: 9516931
    [Abstract] [Full Text] [Related]

  • 15. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A, Dragonetti E, Battista T, Groeger AM, Esposito V, Baldi G, Santini D.
    Anticancer Res; 2000 Feb 15; 20(5C):3923-8. PubMed ID: 11268478
    [Abstract] [Full Text] [Related]

  • 16. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
    Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Thiel E, Foerster MH, Keilholz U.
    Oncology; 2011 Feb 15; 80(1-2):57-62. PubMed ID: 21625180
    [Abstract] [Full Text] [Related]

  • 17. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
    Proebstle TM, Jiang W, Högel J, Keilholz U, Weber L, Voit C.
    Br J Cancer; 2000 Jan 15; 82(1):118-23. PubMed ID: 10638977
    [Abstract] [Full Text] [Related]

  • 18. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P, Nowecki ZI, Kulik J, Ruka W, Siedlecki JA.
    Melanoma Res; 2008 Aug 15; 18(4):246-52. PubMed ID: 18626308
    [Abstract] [Full Text] [Related]

  • 19. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
    Ugurel S, Houben R, Schrama D, Voigt H, Zapatka M, Schadendorf D, Bröcker EB, Becker JC.
    Clin Cancer Res; 2007 Nov 01; 13(21):6344-50. PubMed ID: 17975146
    [Abstract] [Full Text] [Related]

  • 20. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ, Fourkour A, Punt CJ, Ruiter DJ, van Muijen GN.
    Melanoma Res; 2000 Apr 01; 10(2):119-26. PubMed ID: 10803712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.